- cafead   Sep 14, 2022 at 08:12: PM
via For the second time in as many years, Novartis has dodged claims it paid doctors kickbacks at “sham” speaker programs to boost prescriptions of its multiple sclerosis blockbuster Gilenya.
article source
article source